• Concierge-Style Services Becoming a Staple In Clinical Trials

    Clinical Research News | A growing number of companies, many originally in the meetings and events management industry, have pivoted to providing concierge-style services to clinical trial participants, enabling study sponsors to recruit patients faster, retain more of them, and get their outcomes data sooner.

    Oct 11, 2023

  • Navigating the Complex Vendor Selection Process With Dennis Salotti

    Clinical Research News | For clinical research sponsors, selecting the right vendor to do business with is complicated and time-consuming as sponsors deal with a growing number of vendors in the space, data privacy and security concerns, and the need to meet regulatory requirements, often across many different avenues. How does one efficiently navigate such a complex process to ensure downstream success?

    Oct 10, 2023

  • DIA 2023 Topic: The Industry-Wide Definition for RBQM

    Clinical Research News | At an RBQM expert dinner hosted by CluePoints and the Tufts Center for the Study of Drug Development’s (CSDD), Ken Getz shared the results of a global industry-wide survey on RBQM adoption and attitudes. The survey was conducted by Ken and his team at the Tufts CSDD in collaboration with CluePoints and Price Waterhouse Cooper.

    Oct 6, 2023

  • NCI To Conduct Massive Study To Evaluate Multi-Cancer Detection Assays

    Clinical Research News | The importance of data has become apparent to everybody in recent years. We can now interrogate massive datasets to add value to clinical trials and utilize technology more efficiently to speed up time to market.

    Oct 3, 2023

  • Medidata Launches Diversity Program, HHS Extends Partnership to Develop Monoclonal Antibodies, Flatiron Renews FDA Collab

    Clinical Research News | Flatiron Health renewed its collaboration with the Oncology Center of Excellence (OCE) of the United States Food and Drug Administration (FDA) to jointly develop and implement specific research projects; Medidata launched a program to improve diversity, equity, and inclusion in clinical trials; The U.S. Department of Health and Human Services (HHS) announced new details of its agreement with Regeneron to extend its public-private partnership to develop life-saving monoclonal antibodies as part of Project NextGen enhancing our preparedness for COVID-19 strains and variants; and more.

    Sep 28, 2023